跳至主要内容
临床试验/NCT04605952
NCT04605952已完成不适用

Study to Find the Percentage of Cases Retaining COVID-19 IgG Antibodies 45-65 After They Have Tested Positive

Tata Main Hospital1 个研究点 分布在 1 个国家目标入组 201 人开始时间: 2020年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
201
试验地点
1
主要终点
Percentage of cases retaining SARS-CoV-2 IgG antibodies at 45-65 days

研究概览

简要总结

As a serosurveillance measure asymptomatic employees of an industrial workforce Jamshedpur (India) were tested for COVID-19 IgG antibodies. Of the tested employees who were positive for COVID-19 IgG antibodies the study aimed to find the percentage of cases who retained their COVID-19 IgG antibodies 45-65 days after initially testing positive.

详细描述

As a serosurveillance measure, 3296 asymptomatic employees of an industrial workforce Jamshedpur (India) were tested for COVID-19 IgG antibodies specific for the spike subunit antigen by the ErbaLisa COVID-19, Erba Corporate Services (United Kingdom) between 28th June and 15th July 2020.

The cases who tested positive for COVID-19 IgG antibodies were repeat tested for the presence of COVID-19 IgG at 45-65 days after initially testing positive. This was done with the aim of finding out the percentage of cases retaining their IgG antibodies at 45-65 days of initially testing positive.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • SARS-CoV-2 IgG antibody positive between 28th June and 15th July 2020

排除标准

  • SARS-CoV-2 IgG antibody negative between 28th June and 15th July 2020

结局指标

主要结局

Percentage of cases retaining SARS-CoV-2 IgG antibodies at 45-65 days

时间窗: 45-65 days

Percentage of cases retaining SARS-CoV-2 IgG antibodies at 45-65 days

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr.Deb Sanjay Nag

Senior Consultant, Tata Main Hospital

Tata Main Hospital

研究点 (1)

Loading locations...

相似试验